Rotavirus Infections

Infection with any of the rotaviruses. Specific infections include human infantile diarrhea, neonatal calf diarrhea, and epidemic diarrhea of infant mice.
Also Known As:
Infection, Rotavirus; Infections, Rotavirus; Rotavirus Infection
Networked: 652 relevant articles (56 outcomes, 66 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Diarrhea
2. Infection
3. Gastroenteritis
4. Rotavirus Infections
5. Poliomyelitis (Polio)


1. Coulson, Barbara S: 15 articles (10/2015 - 09/2002)
2. Estes, Mary K: 14 articles (11/2014 - 01/2002)
3. Holloway, Gavan: 11 articles (10/2015 - 11/2006)
4. Glass, Roger I: 11 articles (07/2010 - 05/2002)
5. Gentsch, Jon R: 10 articles (06/2015 - 05/2002)
6. Crawford, Sue E: 9 articles (11/2014 - 02/2002)
7. Arias, Carlos F: 8 articles (12/2015 - 03/2002)
8. Blutt, Sarah E: 8 articles (01/2013 - 02/2002)
9. Conner, Margaret E: 8 articles (01/2013 - 01/2002)
10. Jiang, Baoming: 8 articles (07/2012 - 05/2002)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Rotavirus Infections:
1. Immunoglobulin A (IgA)IBA
2. AntibodiesIBA
3. VaccinesIBA
11/01/2009 - "In brief, it was agreed that (1) even vaccines with lesser efficacy in developing countries, compared with industrialized countries, would still lead to substantial public health benefits and would be cost-effective in saving lives in Africa and Asia; (2) criteria, such as the WHO mortality strata and local epidemiology of rotavirus infection, would be appropriate measures for extrapolating the clinical data to other regions and countries; and (3) research toward understanding the programmatic limitations of rotavirus vaccine use may help develop strategies to improve vaccine uptake and overall impact."
01/01/2014 - "Whitehouse Station, New Jersey, USA) vaccines are effective for reducing the morbidity and mortality of rotavirus infection. "
02/01/2013 - "A combination of oral attenuated human rotavirus and intranasal 2/6VLP vaccines conferred immunogenicity, partial protection against a human rotavirus challenge and induced IFN-γ-producing T cells in the ileum of pigs with similar frequencies to human rotavirus infection. "
06/01/2012 - "We reviewed published studies on rotavirus infection and genotype distribution in India, as well as safety and immunogenicity studies of currently available vaccines. "
10/01/2011 - "The diversity of Rotavirus infection in the country is tremendous and since the safety, immunogenicity and efficacy data has not been collected for India, there is first a need to conduct studies to measure the extent of protection and cross-protection provided by the available vaccines for local strains, before venturing into Rotavirus vaccination program. "
4. Rotavirus VaccinesIBA
5. Immunoglobulins (Immunoglobulin)IBA
6. AntigensIBA
7. Immunoglobulin G (IgG)IBA
8. Neutralizing AntibodiesIBA
9. TrypsinIBA

Therapies and Procedures

1. Oral Administration
2. Day Care (Partial Hospitalization)
3. Fluid Therapy (Oral Rehydration Therapy)
4. Transplants (Transplant)
5. Neonatal Intensive Care